WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004009097) USE OF A NAD ANALOGUE, MONO-ADP-RIBOSYL TRANSFERASE SUBSTRATE AND NAD ANTAGONIST, FOR PREPARING A MEDICINE FOR TREATING PATHOLOGIES RELATED TO PURINERGIC RECEPTORS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/009097    International Application No.:    PCT/FR2003/002308
Publication Date: 29.01.2004 International Filing Date: 22.07.2003
IPC:
A61K 31/7084 (2006.01)
Applicants: UNIVERSITE PARIS 7 - DENIS DIDEROT [FR/FR]; 2 place Jussieu, F-75251 PARIS Cedex 05 (FR) (For All Designated States Except US).
UNIVERSITY HOSPITAL HAMBOURG-EPPENDORF [DE/DE]; Martinistrasse 52, 2024 HAMBOURG (DE) (For All Designated States Except US).
SEMAN, Michel [FR/FR]; (FR) (For US Only).
ADRIOUCH, Sahil [FR/FR]; (FR) (For US Only).
KOCH-NOLTE, Friedrich [DE/DE]; (DE) (For US Only).
HAAG, Friedrich [DE/DE]; (DE) (For US Only)
Inventors: SEMAN, Michel; (FR).
ADRIOUCH, Sahil; (FR).
KOCH-NOLTE, Friedrich; (DE).
HAAG, Friedrich; (DE)
Agent: ORES, Béatrice; CABINET ORES, 36 rue de Saint Petersbourg, F-75008 PARIS (FR)
Priority Data:
02 09272 22.07.2002 FR
Title (EN) USE OF A NAD ANALOGUE, MONO-ADP-RIBOSYL TRANSFERASE SUBSTRATE AND NAD ANTAGONIST, FOR PREPARING A MEDICINE FOR TREATING PATHOLOGIES RELATED TO PURINERGIC RECEPTORS
(FR) UTILISATION D'UN ANALOGUE DU NAD, SUBSTRAT DES MONO-ADP-RIBOSYL TRANSFERASES ET ANTAGONISTE DU NAD, POUR LA PREPARATION D'UN MEDICAMENT DESTINE AU TRAITEMENT DES PATHOLOGIES LIEES AUX RECEPTEURS PURINERGIQUES
Abstract: front page image
(EN)The invention concerns the use of at least one NAD analogue, mono-ADP-ribosyl transferase substrate and NAD antagonist, for preparing a medicine designed to modulate the activity of at least one purinergic receptor, advantageously of type P2X or P2Y, said medicine being particularly designed to treat pathologies wherein purinergic receptors are involved in the physiopathological process or pathologies related to deregulation of the activity of purinergic receptors.
(FR)La présente invention est relative a l'utilisation d'au moins un analogue du NAD, substrat des mono-ADP-ribosyl transférases (ART) et antagoniste du NAD, dans la préparation d'un médicament destiné a moduler l'activité d'au moins un récepteur purinergique, avantageusement de type P2X ou P2Y, ledit médicament étant particulièrement destiné au traitement des pathologies dans lesquelles les récepteurs purinergiques participent au processus physiopathologique ou des pathologies liées a une dérégulation de l'activité des récepteurs purinergiques.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: French (FR)
Filing Language: French (FR)